Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases

Andreas Tapia-Arellano,Pablo Cabrera,Elizabeth Cortés-Adasme,Ana Riveros,Natalia Hassan,Marcelo J. Kogan
DOI: https://doi.org/10.1186/s12951-024-02526-0
IF: 10.2
2024-05-15
Journal of Nanobiotechnology
Abstract:The use of nanomaterials in medicine offers multiple opportunities to address neurodegenerative disorders such as Alzheimer's and Parkinson's disease. These diseases are a significant burden for society and the health system, affecting millions of people worldwide without sensitive and selective diagnostic methodologies or effective treatments to stop their progression. In this sense, the use of gold nanoparticles is a promising tool due to their unique properties at the nanometric level. They can be functionalized with specific molecules to selectively target pathological proteins such as Tau and α-synuclein for Alzheimer's and Parkinson's disease, respectively. Additionally, these proteins are used as diagnostic biomarkers, wherein gold nanoparticles play a key role in enhancing their signal, even at the low concentrations present in biological samples such as blood or cerebrospinal fluid, thus enabling an early and accurate diagnosis. On the other hand, gold nanoparticles act as drug delivery platforms, bringing therapeutic agents directly into the brain, improving treatment efficiency and precision, and reducing side effects in healthy tissues. However, despite the exciting potential of gold nanoparticles, it is crucial to address the challenges and issues associated with their use in the medical field before they can be widely applied in clinical settings. It is critical to ensure the safety and biocompatibility of these nanomaterials in the context of the central nervous system. Therefore, rigorous preclinical and clinical studies are needed to assess the efficacy and feasibility of these strategies in patients. Since there is scarce and sometimes contradictory literature about their use in this context, the main aim of this review is to discuss and analyze the current state-of-the-art of gold nanoparticles in relation to delivery, diagnosis, and therapy for Alzheimer's and Parkinson's disease, as well as recent research about their use in preclinical, clinical, and emerging research areas.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?
### Problems Addressed by the Paper The paper primarily explores the application of gold nanoparticles (GNPs) in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, particularly their potential in diagnosis and treatment. Specifically: 1. **Diagnosis**: - Gold nanoparticles can be functionalized to recognize specific pathological proteins (such as Tau protein and α-synuclein), thereby enhancing the sensitivity and specificity of diagnostic signals. - These proteins are present at low concentrations in biological samples (such as blood or cerebrospinal fluid), and gold nanoparticles can amplify these signals, enabling early and accurate diagnosis. 2. **Treatment**: - Gold nanoparticles can be used as drug delivery platforms to transport therapeutic agents directly to the brain, improving treatment efficiency and precision while reducing side effects on healthy tissues. - By functionalizing gold nanoparticles, new therapeutic approaches targeting Tau protein and α-synuclein can be developed. 3. **Challenges and Safety**: - Despite the significant potential of gold nanoparticles, several challenges need to be addressed before clinical application, including ensuring their safety and biocompatibility in the central nervous system. - Rigorous preclinical and clinical studies are required to evaluate the effectiveness and feasibility of these strategies. In summary, the paper aims to discuss and analyze the latest advancements in the use of gold nanoparticles for the diagnosis and treatment of Alzheimer's disease and Parkinson's disease, as well as to explore the challenges and future research directions in this field.